BenoitHenriMulsantMD

Summary

• Benoit Mulsant is Psychiatrist-in-Chief at the Centre for Addiction and Mental Health (CAMH) and is a Vice Chair in the Department of Psychiatry. He is the inaugural Executive Director of the Medical Psychiatry Alliance, a $60-million collaborative partnership between CAMH, The Hospital for Sick Children, Trillium Health Partners, and the University of Toronto with support from the Ministry of Health and Long-Term Care and a private donor.
  
  Dr. Mulsant’s research has focused on improving the treatment of older persons suffering from severe mental disorders. He has designed and conducted clinical trials for “hard to treat” older patients with depression and co-morbid physical illness, psychotic depression, bipolar disorder, schizophrenia, and dementia. For the last 25 years Dr. Mulsant has led and participated in research teams continuously supported by US and Canadian grants in excess of $135 million. In April 2014 he received a $10 million grant from Brain Canada to study the efficacy of a combination of transcranial Direct Current Stimulation (tDCS) and cognitive remediation in the prevention of Alzheimer’s disease in high-risk patients. Dr. Mulsant has (co)authored more than 380 peer-reviewed articles and book chapters, and is among the 1% of research scientists in psychiatry most cited. In recognition of his mentorship of younger physicians and non-MD scientists in the Department of Psychiatry Dr. Mulsant received the Paul E. Garfinkel Award for the Best Fellowship Supervisor. Dr. Mulsant is a member of the editorial boards of both the Canadian Journal of Psychiatry and the American Journal of Geriatric Psychiatry. He is also a Distinguished Fellow of the American Psychiatric Association.
  
  Dr. Mulsant graduated from medical school at Université Laval. He completed his psychiatry residency at the University of Pittsburgh, and a Master of Science at Carnegie Mellon University.